Evidence map›Paper›PMID 35840550›Full record

ArticleNature communications2022

Cutaneous and acral melanoma cross-OMICs reveals prognostic cancer drivers associated with pathobiology and ultraviolet exposure.

Anna Luiza Silva Almeida Vicente, Alexei Novoloaca, Vincent Cahais, Zainab Awada, Cyrille Cuenin, Natália Spitz, André Lopes Carvalho, Adriane Feijó Evangelista, Camila Souza Crovador, Rui Manuel Reis and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Anna Luiza Silva Almeida VicenteMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil. annaluizaalmeida@hotmail.com.ORCID 0000-0003-3902-7772
Alexei NovoloacaEpigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.
Vincent CahaisEpigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.
Zainab AwadaEpigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.
Cyrille CueninEpigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.
Natália SpitzEpigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.ORCID 0000-0003-4776-1758
André Lopes CarvalhoMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Adriane Feijó EvangelistaMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID 0000-0002-4731-2082
Camila Souza CrovadorMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID 0000-0002-9639-7940
Zdenko Herceg *Epigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France.ORCID 0000-0003-4109-3154
Vinicius de Lima Vazquez *Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID 0000-0002-0325-5514
Akram Ghantous *Epigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC), Lyon, France. GhantousA@iarc.who.int.ORCID 0000-0002-2582-6402
Centre international de recherche sur le cancer · FRHospital de Câncer de Barretos · BR

Funding

World Health Organization 001
6 · The paper itself

Abstract

Ultraviolet radiation (UV) is causally linked to cutaneous melanoma, yet the underlying epigenetic mechanisms, known as molecular sensors of exposure, have not been characterized in clinical biospecimens. Here, we integrate clinical, epigenome (DNA methylome), genome and transcriptome profiling of 112 cutaneous melanoma from two multi-ethnic cohorts. We identify UV-related alterations in regulatory regions and immunological pathways, with multi-OMICs cancer driver potential affecting patient survival. TAPBP, the top gene, is critically involved in immune function and encompasses several UV-altered methylation sites that were validated by targeted sequencing, providing cost-effective opportunities for clinical application. The DNA methylome also reveals non UV-related aberrations underlying pathological differences between the cutaneous and 17 acral melanomas. Unsupervised epigenomic mapping demonstrated that non UV-mutant cutaneous melanoma more closely resembles acral rather than UV-exposed cutaneous melanoma, with the latter showing better patient prognosis than the other two forms. These gene-environment interactions reveal translationally impactful mechanisms in melanomagenesis.

Indexed as

MelanomaSkin NeoplasmsCutaneous Malignant MelanomaHumansMutationPrognosisUltraviolet Rays

Identifiers

PMID35840550
PMCPMC9287446
OpenAlexW4285591823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.